We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 41-60 of 410 results

  2. Antineoplastics

    in Reactions Weekly
    Article 15 April 2023

  3. Patient-derived intrafemoral orthotopic xenografts of peripheral blood or bone marrow from acute myeloid and acute lymphoblastic leukemia patients: clinical characterization, methodology, and validation

    Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) are malignant clonal diseases of the hematopoietic system with an unsatisfactory...

    Jun Li, Hongkui Chen, ... Lintao Bi in Clinical and Experimental Medicine
    Article Open access 19 September 2022

  4. Cytarabine/daunorubicin

    in Reactions Weekly
    Article 11 February 2023

  6. Multiple drugs

    in Reactions Weekly
    Article 30 September 2023

  7. Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review

    We present a patient with acute megakaryoblastic leukemia (AMKL) harboring KMT2A-MLLT3 that converted to T cell acute lymphoblastic leukemia (T-ALL)...

    Li Gao, Jun Lu, ... Shaoyan Hu in International Journal of Hematology
    Article 06 December 2022

  9. Homoharringtonine regulates the alternative splicing of Bcl-x and caspase 9 through a protein phosphatase 1-dependent mechanism

    Background

    Homoharringtonine (HHT) is a natural alkaloid with potent antitumor activity, but its precise mechanism of action is still poorly...

    Qi Sun, Shiyue Li, ... Desheng Lu in BMC Complementary and Alternative Medicine
    Article Open access 22 May 2018

  10. Multiple drugs

    in Reactions Weekly
    Article 22 April 2023

  11. Antineoplastics

    in Reactions Weekly
    Article 01 October 2022

  12. Multiple suspects

    in Reactions Weekly
    Article 04 November 2023

  13. Multiple drugs

    in Reactions Weekly
    Article 19 November 2022

  16. Antineoplastics

    in Reactions Weekly
    Article 03 December 2022

  17. Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing

    Aclarubicin (aclacinomycin A) is one of the anthracycline antineoplastic antibiotics with a multifaceted mechanism of antitumor activity. As a...

    Aleksandra Murzyn, Justyna Orzeł, ... Elżbieta Pękala in Cancer Chemotherapy and Pharmacology
    Article Open access 04 July 2024

  19. TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review

    To investigate the pathogenesis and the refractory/relapse mechanisms in patients with t(16;21)(p11;q22), we retrospectively analyzed the clinical...

    Heyang Zhang, Qianru Zhan, ... Lijun Zhang in Annals of Hematology
    Article Open access 01 October 2022

  20. Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting

    Venetoclax (VEN), the first selective Bcl-2 inhibitor, has shown efficacy and safety both as monotherapy and in combination with other agents in the...

    Xubo Gong, Yi Zhang, ... Wenbin Qian in Experimental Hematology & Oncology
    Article Open access 30 June 2023
Did you find what you were looking for? Share feedback.